These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 74352

  • 1. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J, de la Santa López J, Cuadras Avellana CM, Kern A.
    Fortschr Med; 1978 Jan 12; 96(2):75-9. PubMed ID: 74352
    [Abstract] [Full Text] [Related]

  • 2. [Immunosuppresive treatment in chronic hepatitis and liver cirrhosis].
    Evers C, Hesch RD, Banzer D.
    Med Welt; 1969 Feb 22; 8():415-21. PubMed ID: 4181608
    [No Abstract] [Full Text] [Related]

  • 3. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Feb 22; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 4. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.
    Korman MG, Hofmann AF, Summerskill WH.
    N Engl J Med; 1974 Jun 20; 290(25):1399-402. PubMed ID: 4133590
    [No Abstract] [Full Text] [Related]

  • 5. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I, Schmidt FW, Müller R, Ranft U, Wildhirt E, Holzer E, Wallnöfer H, Korb G.
    Dtsch Med Wochenschr; 1980 Mar 07; 105(10):330-2. PubMed ID: 6153953
    [Abstract] [Full Text] [Related]

  • 6. Effects of (+)-cyanidanol-3 on chronic liver injury.
    Kovách G, Salamon F.
    Acta Physiol Hung; 1984 Mar 07; 64(3-4):443-8. PubMed ID: 6152368
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984 Mar 07; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 8. [Therapy of chronic hepatitis using immunosuppressive substances].
    Kommerell B, Seeliger M.
    Dtsch Med Wochenschr; 1970 Dec 11; 95(50):2521-5. PubMed ID: 5484758
    [No Abstract] [Full Text] [Related]

  • 9. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983 Dec 11; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL, Berthet P, Doelle W, Goebell H, Kortüm K, Pelloni S, Peter P, Poulsen H, Strohmeyer G, Tygstrup N.
    Lancet; 1977 Dec 03; 2(8049):1153-5. PubMed ID: 73062
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T.
    Acta Physiol Hung; 1984 Dec 03; 64(3-4):449-54. PubMed ID: 6152369
    [Abstract] [Full Text] [Related]

  • 12. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease.
    Soloway RD, Summerskill WH, Baggenstoss AH, Schoenfield LJ.
    Gastroenterology; 1972 Sep 03; 63(3):458-65. PubMed ID: 4116064
    [No Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K, Hüdepohl M, Schopen RD.
    Med Klin; 1972 Apr 14; 67(15):527-34. PubMed ID: 5053009
    [No Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB.
    Hepatology; 1996 Jun 14; 23(6):1464-7. PubMed ID: 8675165
    [Abstract] [Full Text] [Related]

  • 15. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K, Cueni B, Schmid M.
    Schweiz Med Wochenschr; 1977 Dec 03; 107(48):1749-52. PubMed ID: 929135
    [Abstract] [Full Text] [Related]

  • 16. [The treatment of chronic aggressive hepatitis with D-penicillamine].
    Lange J, Schumacher K, Witscher HP.
    Dtsch Med Wochenschr; 1971 Jan 22; 96(4):139-45 passim. PubMed ID: 5539526
    [No Abstract] [Full Text] [Related]

  • 17. Activity of chronic hepatitis. Correlation of clinical, biochemical and histological parameters in 32 cases.
    Gayotto LC, Strauss E, Alves VA, da Silva LC.
    Rev Inst Med Trop Sao Paulo; 1983 Jan 22; 25(6):288-93. PubMed ID: 6200913
    [No Abstract] [Full Text] [Related]

  • 18. [Studies on juvenile chronic hepatitis].
    Feist D.
    Fortschr Med; 1975 Sep 11; 93(25):1154-8. PubMed ID: 55374
    [Abstract] [Full Text] [Related]

  • 19. [Liver function and morphology in chronic progressive polyarthritis].
    Rau R, Rondez R, Grob P.
    Z Rheumaforsch; 1971 Sep 11; 30(7):205-13. PubMed ID: 4106068
    [No Abstract] [Full Text] [Related]

  • 20. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA, Braconier JH, Eriksson O.
    Scand J Gastroenterol Suppl; 1973 Sep 11; 19():83-91. PubMed ID: 4515643
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.